ABSTRACT
The long noncoding RNA(lncRNA) small nucleolar RNA host gene 3(SNHG3) has been reported to be upregulated in colorectal cancer (CRC). However, its biological role and underlying mechanisms in CRC have not been well studied. The expression levels of SNHG3 were measured in CRC tissues and cell lines by real time quantitative PCR. Functional assays, including the cell counting Kit-8, wound healing and transwell invasion assays, were used to determine the effect of SNHG3 on CRC cell proliferation, migration and invasion,respectively. Furthermore, bioinformatics analysis, dual-Luciferase reporter assays and RNA immunoprecipitation were applied to determine the mechanism of SNHG3 in CRC. Mice xenograft models were established to assess the role of SNHG3 in CRC tumorigenicity and metastasis in vivo.The expression of SNHG3 was significantly upregulated in CRC tissues compared to adjacent normal tissues, which was positively correlated with advanced clinical stage, distant metastasis and poor overall survival. Functional experiments revealed that SNHG3 knockdown significantly decreased CRC growth and metastasis both in vitro and in vivo. Mechanistically, SNHG3 could bind to miR-539, thereby up-regulating the expression of its target gene runt-related transcription factor 2 (RUNX2), and play an oncogenic role in CRC progression. Our works suggest that lncRNA SNHG3 promotes CRC growth and metastasis via regulating miR-539/RUNX2 axis, suggesting that the SNHG3 might be a potential therapeutic target for CRC.
Subject(s)
Colorectal Neoplasms/pathology , Core Binding Factor Alpha 1 Subunit/genetics , MicroRNAs/genetics , RNA, Long Noncoding/genetics , Animals , Cell Line, Tumor , Cell Proliferation/genetics , Colorectal Neoplasms/genetics , Female , Gene Expression Regulation, Neoplastic , Gene Knockdown Techniques , Humans , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Middle Aged , Neoplasm Metastasis/genetics , Survival Rate , Up-Regulation , Xenograft Model Antitumor AssaysABSTRACT
Objective To observe the clinical characteristics and efficacy of laser photocoagulation of aggressive posterior retinopathy of prematurity (AP-ROP).Methods Twenty-eight eyes of 14 infants with AP-ROP from May 2008 to December 2010 were enrolled in this study.The infants were examined using RetCam photography and indirect ophthalmoscopy.Among the 28 eyes,24 eyes were classified as zone one and 4 eyes zone two.All eyes were treated within 24 hours using binocular indirect ophthalmoscope and laser photocoagulation.The initial energy was 200 mW,using energy was 200 - 500 mW,exposure time was 200 ms.Every two photocoagulation spot was linked together,but no overlap.Follow-up ranged from 3 to 24 months,with a mean of 11.5 months. The retinal bloods,the iris surface vessels,the fiber hyperplasia on retina,retinal detachment or ruffle form were observed.Results Twenty-five of 28 eyes (89.3 ％) recovered or were classified as control; 1 of 28 eyes (3.6 ％) was suffered retinal detachment one month after treatment.The detachment was resolved through vitrectomy Surgery.Two of 28 eyes (7.1 ％)did poorly.The parents gave up treatment resulting in loss of vision.No treatment-related complications were observed during the follow-up period,such as damage to cornea,iris and lens. Conclusion Photocoagulation is a safe and effective way to treat most AP-ROP.
